Page last updated: 2024-09-03

gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate and Brain Diseases

gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate has been researched along with Brain Diseases in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19901 (33.33)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Berger, F; Chechin, D; Grand, S; Lahrech, H; Le Bas, JF; Perles-Barbacaru, TA; Sarraf, MG; Tropres, I; Zaccaria, A1
Bonnet, CS; Tóth, E1
Baert, AL; Decrop, E; Marchal, G; Van Hecke, P; Wilms, G1

Reviews

1 review(s) available for gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate and Brain Diseases

ArticleYear
Smart MR imaging agents relevant to potential neurologic applications.
    AJNR. American journal of neuroradiology, 2010, Volume: 31, Issue:3

    Topics: Brain Diseases; Contrast Media; Heterocyclic Compounds; Humans; Magnetic Resonance Imaging; Neurology; Organometallic Compounds

2010

Other Studies

2 other study(ies) available for gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate and Brain Diseases

ArticleYear
Technical Note: Clinical translation of the Rapid-Steady-State-T1 MRI method for direct cerebral blood volume quantification.
    Medical physics, 2015, Volume: 42, Issue:11

    Topics: Algorithms; Blood Flow Velocity; Blood Volume; Blood Volume Determination; Brain; Brain Diseases; Cerebrovascular Circulation; Computer Simulation; Contrast Media; Feasibility Studies; Heterocyclic Compounds; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Imaging, Three-Dimensional; Magnetic Resonance Angiography; Models, Biological; Organometallic Compounds; Reproducibility of Results; Sensitivity and Specificity

2015
MR imaging of the brain: preliminary results with a gradient echo sequence after paramagnetic contrast enhancement.
    Journal belge de radiologie, 1989, Volume: 72, Issue:2

    Topics: Brain Diseases; Brain Neoplasms; Contrast Media; Gadolinium; Heterocyclic Compounds; Humans; Image Enhancement; Magnetic Resonance Imaging; Organometallic Compounds; Time Factors

1989